Gorlin Syndrome Presentation and the Importance of Differential Diagnosis of Skin Cancer: A Case Report
DOI:
https://doi.org/10.18433/jpps30150Abstract
In a busy community practice, clinical skin findings can often be misinterpreted. Skin cancers can sometimes mimic rashes like psoriasis, eczema or prurigo nodularis in both appearance and symptoms. Gorlin syndrome is one such genetic syndrome, characterized by the eruption of multiple and early onset basal cell carcinomas (BCCs), which can be mistaken for a rash. We describe a 68-year-old female who presented to the dermatology office with a previous history of over 30 BCCs that had been previously biopsied and/or surgically removed. However, the patient had been lost to follow up for several years and had not been seen by a skin specialist. In the interim, she had been misdiagnosed as having eczematous or psoriatic lesions by primary care providers. Patients with Gorlin syndrome are even harder to diagnose as their skin cancers often do not possess the classic features associated with a basal cell or squamous cell carcinoma. When in doubt, and especially if failing topical therapy, patients presenting with dermatological lesions should be properly referred to a specialist for further assessment and workup.
Downloads
References
Basal cell naevus syndrome. In: DermNetNZ. 2018 [cited August 2018]. Available from: https://www.dermnetnz.org/topics/basal-cell-naevus-syndrome/
Spiker AM, Ramsey ML. Gorlin Syndrome (Basal Cell Nevus) [Updated 2017 Feb 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. Available from: https://www-ncbi-nlm-nih-gov.login.ezproxy.library.ualberta.ca/books/NBK430921/
Gorlin syndrome [Internet]. In: U.S. National Library of Medicine. 2012 [cited August 2018]. Available from: https://ghr.nlm.nih.gov/condition/gorlin-syndrome#statistics
Downloads
Published
How to Cite
Issue
Section
License
This is an open access journal with free of charge non-commercial download. At the time of submission, authors will be asked to transfer the copyright to the accepted article to the Journal of Pharmacy and Pharmaceutical Sciences. The author may purchase the copyright for $500 upon which he/she will have the exclusive copyright to the article. Nevertheless, acceptance of a manuscript for publication in the Journal is with the authors' approval of the terms and conditions of the Creative Commons copyright license Creative Common license (Attribution-ShareAlike) License for non-commercial uses.
CLOCKSS system has permission to collect, preserve, and serve this Archival Unit.